Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JPEN. Journal of Parenteral and Enteral Nutrition|March 1, 1985
Energy requirements of parenterally fed bone marrow transplant recipientsD J Szeluga, R K Stuart, R Brookmeyer, et al.
The Journal of Clinical Investigation|August 1, 1974
Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic feverS E Read, V A Fischetti, V Utermohlen, et al.
The Pediatric Infectious Disease Journal|March 1, 1990
Impact of asymptomatic congenital cytomegalovirus infection on size at birth and gestational durationP Berge, S Stagno, W Federer, et al.
The Nurse Practitioner|June 1, 1997
Drug-nutrient interactions in enteral feeding: a primary care focusL Varella, E Jones, M M Meguid
Nutrition (Burbank, Los Angeles County, Calif.)|November 1, 1994
Nutrition management of acute intermittent porphyriaT L Robert, L Varella, M M Meguid
Biotechnology and Bioengineering|July 1, 1984
Continuous enzymatic cooking and liquefaction of starch using the technique of direct resistive heatingV L Varella, B R Concone, J T Senise, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|January 1, 1990
Growth response to enteral feeding by children with cerebral palsyK D Sanders, K Cox, R Cannon, et al.
Genetics and Molecular Research : GMR|November 26, 2016
Effect of fragmentation on the natural genetic diversity of Theobroma speciosum Willd. ex Spreng. populationsT L Varella, A A B Rossi, J F E Dardengo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancerE L Mayer, D Trapani, S-E Kim, et al.
ESMO Open|July 6, 2026
TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancerI Schlam, D Trapani, S-E Kim, et al.
Pageof 2